1. Home
  2. VTR vs HLN Comparison

VTR vs HLN Comparison

Compare VTR & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ventas Inc.

VTR

Ventas Inc.

HOLD

Current Price

$80.81

Market Cap

35.2B

Sector

Real Estate

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.77

Market Cap

41.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTR
HLN
Founded
1983
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Package Goods/Cosmetics
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
35.2B
41.7B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
VTR
HLN
Price
$80.81
$9.77
Analyst Decision
Buy
Hold
Analyst Count
13
1
Target Price
$77.92
N/A
AVG Volume (30 Days)
3.2M
9.0M
Earning Date
10-29-2025
07-31-2025
Dividend Yield
2.38%
1.85%
EPS Growth
N/A
41.64
EPS
0.53
0.23
Revenue
$5,544,046,000.00
$15,096,588,575.00
Revenue This Year
$16.61
$1.41
Revenue Next Year
$9.31
$4.52
P/E Ratio
$152.84
$20.97
Revenue Growth
16.38
N/A
52 Week Low
$56.68
$8.71
52 Week High
$80.99
$11.42

Technical Indicators

Market Signals
Indicator
VTR
HLN
Relative Strength Index (RSI) 77.34 57.18
Support Level $78.39 $9.65
Resistance Level $80.50 $9.84
Average True Range (ATR) 1.00 0.12
MACD 0.03 0.00
Stochastic Oscillator 95.75 62.04

Price Performance

Historical Comparison
VTR
HLN

About VTR Ventas Inc.

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: